CVS Health Corp.’s stock tumbled 10.5% early Friday, after the healthcare company announced leadership changes and lowered ...

To arrest that rise, and boost sales and profits at its retail pharmacy division, CVS said Friday that it has replaced CEO ...

The stock fell over 12% to $56.60 in premarket trading Friday. Joyner is currently president of the company’s ...

CVS Health chief executive officer Karen Lynch has stepped down and will be replaced by David Joyner who run's the company's ...

CVS Health CEO Karen Lynch has stepped down and is being replaced by David Joyner as the health care giant continues to ...

Joyner, who heads CVS’s pharmacy-benefit business Caremark, will succeed Karen Lynch.

CVS Health on Friday named company veteran David Joyner as new CEO, succeeding Karen Lynch who stepped down from the helm of ...

The change comes on the back of repeated profit forecast cuts this year as the company's insurance segment has struggled with ...

Shares tumbled premarket after the struggling healthcare company named a new chief executive and guided for third-quarter results below Wall Street expectations. Find out more: ...

Deal Overview CVS Health a leading health solutions company in the US, is considering a potential break-up to separate its ...

Adjusted EPS of $1.83 decreased from $2.21 in the prior year, beating the consensus of $1.73. In Q2 earnings, CVS Health revised its 2024 adjusted EPS guidance to $6.40-$6.65 from at least $7.00 ...

CVS is naming longtime executive David Joyner as its new chief, replacing Lynch. Joyner has been president of CVS Caremark, ...